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To assess human exposure to Simian immunodeficiency virus (SIV) in west central Africa, we looked for SIV
infection in 788 monkeys that were hunted in the rainforests of Cameroon for bushmeat or kept as pets.
Serologic reactivity suggesting SIV infection was found in 13 of 16 primate species, including 4 not previously
known to harbor SIV. Overall, 131 sera (16.6%) reacted strongly and an additional 34 (4.3%) reacted weakly
with HIV antigens. Molecular analysis identified five new phylogenetic SIV lineages. These data document
for the first time that a substantial proportion of wild monkeys in Cameroon are SIV infected and that humans
who hunt and handle bushmeat are exposed to a plethora of genetically highly divergent viruses.
irst recognized in the early 1980s, AIDS represents the
endstage of infection with one of two lentiviruses, termed
Human immunodeficiency virus type 1 (HIV-1) or type 2 (HIV-
2) (1,2). HIV-1 has spread to most parts of the world, while
HIV-2 has remained largely restricted to West Africa (3,4).
More than 40 million persons are estimated to have HIV infec-
tion or AIDS (4). 
Both HIV-1 and HIV-2 are of zoonotic origin (5). The clos-
est simian relatives of HIV-1 and HIV-2 have been found in
the common chimpanzee (Pan troglodytes) and the sooty man-
gabey (Cercocebus atys), respectively (6-8), and phylogenetic
evidence indicates that lentiviruses from these species (SIVcpz
and SIVsm, respectively) have been transmitted to humans on
at least eight occasions (5,9). Serologic evidence of SIV infec-
tion has so far been documented in 26 primate species, and 20
of these viruses have been at least partially molecularly char-
acterized (5,10,11). Because humans come in frequent contact
with primates in many parts of sub-Saharan Africa, additional
zoonotic transfers of primate lentiviruses from species other
than chimpanzees and sooty mangabeys are possible. The risk
for acquiring SIV infection would be expected to be highest in
persons who hunt primates and prepare their meat for con-
sumption, as well as in persons who keep primates as pets.
However, this risk cannot be assessed since the prevalence,
diversity, and geographic distribution of SIV infections in wild
primate populations are unknown. We report the first compre-
hensive survey of wild-caught primates in Cameroon, home to
diverse primate species that are extensively hunted for food
and trade (12). Much of the primate meat sold for consumption
derives from infected monkeys, and a comparable number of
pet monkeys also carry SIV. These data thus provide a first
approximation of the magnitude and variety of SIVs to which
humans are exposed through contact with nonhuman primates. 
Materials and Methods
Collection of Primate Tissue and Blood Samples
Blood was obtained from 788 monkeys wild-caught in
Cameroon from January 1999 to April 2001. Species were
determined by visual inspection according to the Kingdon Field
Guide to African Mammals (13) and the taxonomy described
by Colin Groves (14). We sampled 573 animals as bushmeat at
markets in Yaounde (n=157), surrounding villages (n=111), or
logging concessions in southeastern Cameroon (n=305), as
well as 215 pet animals from these same areas (Table 1). All
primate samples were obtained with government approval from
the Cameroonian Ministry of Environment and Forestry. Bush-
meat samples were obtained through a strategy specifically
designed not to increase demand: women preparing and pre-
serving the meat for subsequent sale and hunters already
involved in the trade were asked for permission to sample
blood and tissues from carcasses, which were then returned. 
For the bushmeat animals, blood was collected by cardiac
puncture, and lymph node and spleen tissues were collected
whenever possible. The owners indicated that most of the ani-
mals had died 12 to 72 hours before sampling. For pet mon-
keys, blood was drawn by peripheral venipuncture after the
animals were tranquilized with ketamine (10 mg/kg). Plasma
and cells were separated on site by Ficoll gradient centrifuga-
tion. All samples, including peripheral blood mononuclear
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cells (PBMCs), plasma, whole blood, and other tissues, were
stored at –20°C.
Serologic Testing
Plasma samples were tested for HIV/SIV antibodies by the
INNO-LIA HIV Confirmation test (Innogenetics, Ghent, Bel-
gium), which includes HIV-1 and HIV-2 recombinant proteins
and synthetic peptides that are coated as discrete lines on a
nylon strip. Five HIV-1 antigens include synthetic peptides for
the exterior envelope glycoprotein (sgp120), as well as recom-
binant proteins for the transmembrane envelope glycoprotein
(gp41), integrase (p31), core (p24), and matrix (p17) proteins.
HIV-1 group O envelope peptides are included in the HIV-1
sgp120 band. The HIV-2 antigens include synthetic peptides
for sgp120, as well as recombinant gp36 protein. In addition to
these HIV antigens, each strip has control lines: one sample
addition line (3+) containing anti-human immunoglobulin (Ig)
and two test performance lines (1+ and +/-) containing human
IgG. All assays were performed according to manufacturer’s
instructions, with alkaline phosphatase-labeled goat anti-
human IgG as the secondary antibody. We used the following
working definition for SIV seropositivity: plasma samples
were scored as INNO-LIA positive when they reacted with at
least one HIV antigen and had a band intensity equal to or
greater than the assay cutoff (+/-) lane; samples that reacted
less strongly but still visibly with two or more HIV antigens
were classified as indeterminant; and samples reacting with no
bands or only one band with less than +/- intensity were classi-
fied as negative.
Polymerase Chain Reaction (PCR)
DNA was isolated from whole blood or PBMCs by using
Qiagen DNA extraction kits (Qiagen, Courtaboeuf, France),
and PCR was done with the Expand High Fidelity PCR kit
(Roche Molecular Biochemicals, Mannheim, Germany). For
amplification of SIV sequences, previously described degener-
ate consensus pol primers DR1, Polis4, UNIPOL2, and PolOR
(15-17) were used in various combinations under previously
described PCR conditions (16). PCR products were sequenced
by cycle sequencing and dye terminator methods (ABI PRISM
Big Dye Terminator Cycle Sequencing Ready Reaction kit
with AmpliTaq FS DNA polymerase [PE Biosystems, War-
rington, England]) on an automated sequencer (ABI 373,
Stretch model; Applied Biosystems, Courtaboeuf, France)
either directly or after cloning into the pGEM-T vector
(Promega, Charbonnieres, France).
To test for DNA degradation, a 1,151-bp region of the glu-
cose-6–phosphate dehydrogenase (G6PD) gene was amplified
with the primers GPD-F1 5'-CATTACCAGCTCCATGAC-
CAGGAC-3' and GPD-R1 5'-GTGTTCCCAGGTGACCCTC-
TGGC-3' in a single-round PCR reaction under the following
conditions: 94°C for 2 min, then 35 cycles at 94°C for 20 sec;
58°C for 30 sec, and 72°C for 1 min (18).
Phylogenetic Analyses
Newly derived SIV nucleotide sequences were aligned
with reference sequences from the Los Alamos HIV/SIV
Sequence database by using CLUSTAL W (19) with minor
adjustments for protein sequences. A phylogenetic tree was
Table 1. Wild-born primates surveyed, by species, age, and status, Cameroon
Genus Species Common name
Pet animals Primate bushmeat
Total Adults Juveniles/infants Adults Juveniles/infants
Cercocebus agilis Agile mangabey 4 15 30 3 52
torquatus Red-capped mangabey 1 – – 1 2
Lophocebus albigena Grey-cheeked mangabey 3 3 12 3 21
Cercopithecus cephus Mustached guenon 3 26 217 56 302
mona Mona monkey – 7 1 1 9
neglectus De Brazza’s monkey 2 6 21 5 34
nictitans Greater spot-nosed monkey 8 36 110 12 166
pogonias Crested mona 1 5 57 10 73
preussi Preuss’s monkey – 1 – – 1
Chlorocebus tantalus Tantalus monkey 7 11 – – 18
Miopithecus ogouensis Gabon talapoin 5 6 8 – 19
Erytrocebus patas Patas monkey 5 14 – – 19
Colobus guereza Mantled guereza – 2 24 – 26
Mandrillus leucophaeus Drill – 2 – – 2
sphinx Mandrill 5 15 – 2 22
Papio anubis Olive baboon 11 11 – – 22
Total 55 160 480 93 788Emerging Infectious Diseases  •  Vol. 8, No. 5, May 2002 453
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constructed by the neighbor-joining method (20), and the reli-
ability of branching orders was tested by the bootstrap
approach  (21). Sequence distances were calculated by
Kimura’s two-parameter method  (22). SIV lineages were
defined as clusters of SIV sequences from the same primate
species that grouped together with significant (>80%) boot-
strap values. 
GenBank Accession Numbers
The new sequences have been deposited in GenBank under
the following accession numbers: SIVgsn-99CM-CN71
(AF478588), SIVgsn-99CM-CN7 (AF478589), SIVgsn-99CM-
CN166 (AF478590), SIVmon-99CM-CML1 (AF478591), SIV-
mus-01CM-S1239 (AF478592), SIVmus-01CM-S1085 (AF47
8593), SIVtal-00CM-271 (AF478594), SIVtal-00CM-266
(AF478595), SIVmnd2-99CM-54 (AF478596), SIVmnd2-01C
M-S109 (AF478597), SIVmnd2-00CM-S46 (AF478598),
SIVmnd2-00CM-S6 (AF478599), SIVdeb-01CM-1083 (AF47
8600), SIVdeb-99CM-CN40 (AF478601), SIVdeb-01CM-
S1014 (AF478602), SIVdeb-99CM-CNE5 (AF478603), SIV
deb-01CM-1161 (AF478604), SIVdeb-99CM-CNE1 (AF47
8605), SIVcol-00CM-247 (AF478606), SIVcol-00CM-243
(AF478607), and SIVcol-99CM-11 (AF478608).
Results
Prevalence Estimates of SIV Infection 
in Bushmeat and Pet Monkey Samples
Previous studies of SIV infection have relied almost exclu-
sively on surveys of captive monkeys or apes that were either
kept as pets or housed at zoos, sanctuaries, or primate centers.
While this approach has led to the discovery of novel SIVs
(23-29), it has not provided information concerning SIV prev-
alence rates in the wild. Most pet monkeys are acquired at a
very young age, often when their parents are killed by hunters.
Two field studies of wild African green monkeys have shown
that seroprevalence rates correlated with sexual maturity, sug-
gesting transmission predominantly by sexual routes (30,31).
SIV infection rates of captive monkeys may thus not accu-
rately reflect SIV prevalence rates in the wild. 
To ensure systematic sampling, we therefore collected
blood from 573 monkeys sold as bushmeat and 215 pet mon-
keys (Table 1). Most of the bushmeat animals were adults,
while most of the pets were still infants or juveniles at the time
of sampling. Most primates came from the southern part of the
country. All major SIV lineages known to date were initially
discovered because their primate hosts had antibodies that
cross-reacted with HIV-1 or HIV-2 antigens (23-29). Although
the extent of this cross-reactivity has not been defined, we
used a similar approach to examine the primate blood samples
obtained in Cameroon. Since commercially available HIV
screening assays (e.g., enzyme-linked immunosorbent assay or
rapid tests) contain only a limited number of antigens, we used
an HIV confirmatory assay (INNO-LIA), comprising a recom-
binant and synthetic peptide-based line immunoassay (Figure
1). One hundred thirty-one (16.6%) of 788 plasma samples
reacted strongly with one or more HIV antigens, while an
additional 34 samples (4.3%) reacted less strongly but visibly
with two or more HIV antigens (Figure 1; Table 2). Of 13 pri-
mate species that had HIV cross-reactive antibodies, the preva-
lence of seroreactivity (positive plus indeterminant) ranged
from 5% to 40%. Prevalences were lower in pet animals than
in bushmeat primates, 11.6% versus 18.4%, respectively. Sera
from only three species failed to react completely (Cercopithe-
cus preussi, Mandrillus leucophaeus, Cercocebus torquatus),
but these three species accounted for only 5 of the 788 samples
tested.
 
Figure 1. Detection of HIV-1/HIV-2 cross-reactive antibodies in sera from 11 primate species by using a line immunoassay (INNO-LIA HIV Confir-
mation, Innogenetics, Ghent, Belgium). Varying patterns of reactivity to HIV peptides and proteins (HIV-1 gp120, gp41, p31, p24, and p17; HIV-2
gp130, and gp36) are shown. Samples from which Simian immunodeficiency virus (SIV) sequences were subsequently amplified by polymerase
chain reaction are color-coded as in Figure 2. Plasma samples from HIV-1/HIV-2-negative and -positive persons are shown as controls on the left.
The 3+, 1+ and +/- bands at the top of all test strips control for sample addition (presence of plasma immunoglobulin) and test performance (bind-
ing of secondary antibody). RESEARCH
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The INNO-LIA profiles from members of the same as well
as different primate species varied extensively (Figure 1).
Some sera reacted only with HIV core and/or Pol proteins,
while others reacted with Gag and/or Pol and/or Env proteins
from either HIV-1 or HIV-2 or both. Other than classifying
sera as INNO-LIA reactive or nonreactive, no banding pattern
or algorithm could be derived that would have been predictive
of infection of any given primate species. 
Confirmation of SIV Infection by 
PCR and Discovery of Novel SIV Lineages
A total of 342 samples, including INNO-LIA positive
(n=91), indeterminant (n=23), or negative (n=228) specimens,
were subjected to PCR analysis (16,32), which yielded ampli-
fication products for 28 blood samples from seven primate
species:  Cercopithecus mona,  C. neglectus,  C. nictitans,  C.
cephus, Colobus guereza, Miopithecus ogouensis, and Man-
drillus sphinx (Table 3). All these amplification products were
of appropriate size. Moreover, subsequent sequence and phy-
logenetic analysis confirmed SIV infection (Figure 2). Most of
the newly derived sequences did not fall into any of the known
SIV groups. Viral sequences from C. mona (SIVmon),  C.
neglectus (SIVdeb), C. nictitans (SIVgsn), C. cephus (SIV-
mus), and Miopithecus ogouensis (SIVtal) formed species-spe-
cific monophyletic clusters that were roughly equidistant from
each other as well as from all previously defined SIV lineages
in this region of the pol gene. Viruses from the remaining two
species (Colobus guereza and Mandrillus sphinx) grouped
with previously reported SIVcol and SIVmnd-2 strains,
respectively. 
The single sequence of SIVmon was given lineage status
because of its high degree of genetic diversity from the other
SIV strains. We maintained the lineage designation of SIVtal
previously assigned to a virus thought to be derived from a zoo
animal of the species M. talapoin (28) because that sequence
and the two newly derived talapoin viruses from M. ogouensis
cluster together in a phylogenetic tree derived from additional
pol nucleotide sequences (not shown). Thus, our new SIVtal
sequences confirm the existence of this lineage in the wild .
SIV sequences were confirmed in 26 of 91 INNO-LIA-
positive samples, as well as in 1 of 23 indeterminate and 1 of
223 negative samples (Table 3). Because many blood samples
were obtained under poorly controlled circumstances, espe-
cially from the bushmeat markets, we tested the possibility of
DNA degradation. Whole blood and PBMC DNA preparations
were subjected to single-round PCR with primers designed to
amplify introns 4 and 5 of the nuclear G6PD gene (1,100 bp).
Of the 65 LIA-positive samples that did not yield a virus-spe-
cific PCR product, 11 also failed to yield a G6PD amplifica-
tion product. Similarly, 4 of 17 INNO-LIA-indeterminate and
SIV PCR-negative samples, as well as 25 of 102 INNO-LIA-
negative samples, were also negative by G6PD amplification.
Table 2. HIV-1/HIV-2 cross-reactive antibodiesa detected in primate species, Cameroon
Genus Species Common name
Pet animals Primate bushmeat Total
pos/tested ind/tested pos/tested ind/tested pos/tested ind/tested
Cercocebus agilis Agile mangabey  1/19 1/19 5/33 7/33 6/52 8/52
torquatus Red-capped mangabey 0/1 0/1 0/1 0/1 0/2 0/2
Lophocebus albigena Grey-cheeked mangabey 0/6 0/6 2/15 3/15 2/21 3/21
Cercopithecus cephus Mustached guenon 1/29 3/29 48/273 9/273 49/302 12/302
mona Mona monkey 1/7 0/7 1/2 0/2 2/9 0/9
neglectus De Brazza’s monkey  1/8 0/8 9/26 1/26 10/34 1/34
nictitans Greater spot-nosed monkey 6/44 0/44 22/122 3/122 28/166 3/166
pogonias Crested mona  0/6 0/6 9/67 4/67 9/73 4/73
preussi Preuss’s monkey  0/1 - - - 0/1 -
Chlorocebus tantalus Tantalus monkey 3/18 0/18 - - 3/18 0/18
Miopithecus ogouensis Gabon talapoin  2/11 1/11 2/8 0/8 4/19 1/19
Erythrocebus patas Patas monkey  1/19 0/19 - - 1/19 0/19
Colobus guereza Mantled guereza  0/2 0/2 7/24 1/24 7/26 1/26
Mandrillus leucophaeus Drill 0/2 0/2 - - 0/2 0/2
sphinx Mandrill 7/20 0/20 1/2 1/2 8/22 1/22
Papio anubis Olive baboon 2/22 0/22 - - 2/22 0/22
Total 25/215 5/215 106/573 29/573 131/788 34/788
(%) 11.6% 2.3% 18.4% 5.1% 16.6% 4.3%
aPlasma samples were tested for antibodies cross-reactive with HIV-1 and HIV-2 antigens by using a recombinant-based line immunoassay (INNO-LIA HIV Confirmation,
 Innogenetics, Ghent, Belgium). Positive (pos) and indeterminant (ind) INNO-LIA scoring criteria as described in Methods.Emerging Infectious Diseases  •  Vol. 8, No. 5, May 2002 455
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These results indicate that, in addition to using only a single
set of nested pol primer pairs, low PCR amplification rates
from LIA-positive and -indeterminant samples were also due
to DNA degradation, the presence of PCR inhibitors, or both. 
Discussion
Zoonotic transfers of SIV to humans have been docu-
mented on no fewer than eight occasions (5,9), but no previous
study has examined to what extent African primates that are
frequently hunted or kept as pets are infected with SIV.
Although our serologic screening approach has limitations
(i.e., an unknown extent of antigenic cross-reactivity between
HIV proteins and SIV antibodies), we were able to detect
cross-reactive antibodies suggesting SIV infection in 16.6% of
all tested animals, including members of four species not pre-
viously known to harbor SIV (C. agilis, Lophocebus albigena,
C. pogonias, and Papio anubis). PCR confirmation and molec-
ular identification of SIV infection were obtained in seven spe-
cies, and phylogenetic analyses showed the presence of highly
divergent viruses that grouped according to their species of
origin. Four of these SIV lineages from mona (C. mona), De
Brazza’s (C. neglectus), mustached (C. cephus), and greater
spot-nosed (C. nictitans) monkeys have not previously been
recognized. Finally, we confirmed the SIVtal infection of wild
talapoin monkeys (Miopithecus ogouensis). These data estab-
lish for the first time that a considerable proportion of wild-
living primates in Cameroon are infected with SIV, posing a
potential source of infection to those who come in contact with
them. Our findings bring to 30 the number of African nonhu-
man primate species known or strongly suspected to harbor
primate lentiviruses (5).
Our data likely still underestimate the prevalence and
diversity of naturally occurring SIV infections in Cameroon.
First, not all native primate species were tested, and many
were undersampled because they were either rare in the
regions of Cameroon where we sampled for this study or too
small to be regularly hunted. For example, the absence of reac-
tive sera from drills and red-capped mangabeys, two species
known to harbor SIV (15,23), must be due to the low number
of blood samples (5/788) analyzed. In addition, the INNO-LIA
test sensitivity is clearly not 100%, as one negative sample
contained SIV sequences as determined by PCR amplification.
Finally, our PCR approach, which utilized only a single set of
nested primers, likely amplified only a subset of viral sequences.
Thus, the true prevalence of SIV infection in the various primate
species will require the development of SIV lineage-specific
assays with known sensitivities and specificities. 
Human infection with SIVcpz and SIVsm is thought to
Figure 2. Identification of diverse Simian immunodeficiency virus (SIV)
lineages in primate bushmeat. A 650-bp pol fragment was amplified
from monkeys representing seven primate species, sequenced, and
subjected to phylogenetic tree analysis by the neighbor-joining method.
The positions of 21 SIV sequences from the present study (in color) are
shown in relation to HIV/SIV reference sequences from the Los Alamos
HIV/SIV Sequence Database (in black). The consensus length of the
final alignment used for tree construction was 555 bp. The new spe-
cies-specific SIV lineages are generally identified by a lower-case
three-letter code corresponding to the initial letters of the common spe-
cies name (e.g., SIVgsn for greater spot-nosed monkeys [Cercopithe-
cus nictitans], SIVmus for mustached guenons [C. cephus] and SIVmon
for mona monkeys [C. mona]). Lineages are defined as clusters of viral
sequences from the same primate species that group together with sig-
nificant (>80%) bootstrap values. We maintained the lineage designa-
tion of SIVtal previously assigned to a virus thought to be derived from
a zoo animal of the species Miopithecus talapoin (28) since that
sequence, and the two newly derived talapoin viruses from M. ogouen-
sis, cluster together in a phylogenetic tree derived from additional pol
nucleotide sequences (not shown). Branch lengths are drawn to scale
(the bar indicates 10% divergence). The numbers at the nodes indicate
the percent bootstrap values supporting the cluster to the right (only
values >80% are shown).
Table 3. Polymerase chain reaction (PCR) amplification of Simian 
immunodeficiency virus (SIV) sequences
Genus Species
 INNO-LIA 
posa PCR 
pos/tested
 INNO-LIA 
ind PCR 
pos/tested
 INNO-LIA neg
PCR pos/tested
Cercocebus agilis 0/6 0/8 0/13
torquatus – – 0/1
Lophocebus albigena 0/2 0/2 0/7
Cercopithecus cephus 2/25 0/7 0/56
mona 1/2 – 0/2
neglectus 8/9 – 0/4
nictitans 3/21 1/1 0/61
pogonias 0/9 0/3 0/34
Chlorocebus tantalus 0/1 – 0/2
Miopithecus ogouensis 2/3 – 0/10
Erythrocebus patas – – 0/7
Colobus guereza 6/6 0/1 1/16
Mandrillus sphinx 4/5 0/1 0/4
Papio anubis 0/2 – 0/11
Total 26/91 1/23 1/228
aDNA was extracted from a subset of seropositive (pos), indeterminant (ind) and nega-
tive (neg) blood samples and subjected to nested PCR amplification by using HIV/SIV 
consensus pol primer pairs. In each column, the number of PCR-positive samples per 
total number of samples tested is indicated. The authenticity of all amplification prod-
ucts was confirmed by sequence analysis. RESEARCH
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have resulted from cutaneous or mucous membrane exposure
to infected blood during the hunting and butchering of chim-
panzees and sooty mangabeys for food (5). Bites from pet ani-
mals and possibly contact with fecal and urine samples may
have also been involved (5). Our study shows that many pri-
mate species in addition to chimpanzees and sooty mangabeys
are hunted and that 20% (or more) of these animals likely har-
bor SIV. Thus, if contact with infected blood or other secre-
tions is indeed the primary route of transmission, hunters and
food handlers may be at risk of infection with many more SIVs
than just those from chimpanzees and sooty mangabeys. 
Bushmeat hunting, to provide animal proteins for the fam-
ily and as a source of income, has been a longstanding com-
mon component of household economies in the Congo Basin
and, more generally, throughout subSaharan Africa (33-35).
However, the bushmeat trade has increased in the last decades.
Commercial logging, which represents an important economic
activity in Cameroon as well as many other west-central Afri-
can countries, has led to road constructions into remote forest
areas, human migration, and social and economic networks
supporting this industry (36). Hunters are now penetrating pre-
viously inaccessible forest areas, making use of newly devel-
oped infrastructure to capture and transport bushmeat from
remote areas to major city markets (37). Moreover, villages
around logging concessions have grown from a few hundred to
several thousand inhabitants in just a few years (37). These
socioeconomic changes, combined with our estimates of SIV
prevalence and genetic complexity in wild primates, suggest
that the magnitude of human exposure to SIV has increased, as
have the social and environmental conditions that would be
expected to support the emergence of new zoonotic infections. 
Whether any of the newly identified SIVs have the ability
to infect humans remains unknown since molecular evidence
is lacking for SIV cross-species transmissions from primates
other than chimpanzees and sooty mangabeys. However, such
infections may have been unrecognized by HIV-1/HIV-2
screening assays. A case in point is the recent identification of
a Cameroonian man who had an indeterminant HIV serology
but reacted strongly (and exclusively) with an SIVmnd V3
loop peptide (32). Although viral sequences were not con-
firmed in this man, the finding suggests that at least some nat-
urally occurring SIVs have the potential to cross the species
into the human population. In fact, several recently reported
SIV isolates, including SIVlhoest, SIVsun, SIVrcm, and
SIVmnd2, replicate well in primary human lymphocytes in
vitro  (23,26,27,32,38) as do SIVcpz (25) and SIVsm (24).
Thus, to determine whether additional zoonotic transmissions
of SIVs have already occurred, virus type- and/or lineage-spe-
cific immunoassays and PCRs will have to be developed. Such
work should receive high priority given the extent of human
exposure to different SIV lineages as a result of the expanding
bushmeat trade and the impact of two major human zoonoses
(HIV-1 and HIV-2). Recombination between newly introduced
SIVs and circulating HIVs poses still another human risk for
novel zoonoses. 
In summary, the current HIV-1 pandemic provides compel-
ling evidence for the rapidity, stealth, and clinical impact that
can be associated with even a single primate lentiviral
zoonotic transmission event. We document for the first time
that humans are exposed to a plethora of primate lentiviruses
through hunting and handling of bushmeat in Cameroon, a
country at the center of HIV-1 groups M, N, and O endemicity
that is home to a diverse set of SIV-infected nonhuman pri-
mates. To what extent wild monkey populations in other parts
of Africa are also infected with diverse SIVs is unknown. A
complete and accurate assessment of all SIV-infected nonhu-
man primate species is needed, as well as a determination of
the virus lineage(s) present in each species. Studies are also
needed to determine whether zoonotic transmissions of SIVs
from primates other than chimpanzees and mangabeys have
already occurred and what clinical outcomes were associated
with these infections. Results from these studies will yield crit-
ical insights into the circumstances and factors that govern
SIV cross-species transmission and thus allow determination
of human zoonotic risk for acquiring these viruses.
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